Jaguar Health Inc (NASDAQ:JAGX) Stock Suddenly Jump 125: What Next?

October 26, 2021

There was no material news about Jaguar Health Inc (NASDAQ:JAGX) on Monday but the stock was in sharp focus among investors and ended up with gains of as much as 12% amidst heavy action. Market Reaction: On Monday, JAGX stock moved up 12% at $2.02 with more than 9.58 million shares, compared to its average volume of 1.46 million shares. The stock has moved within a range of $1.8300 –…


Jaguar Health Inc (JAGX) Stock In Focus After The Recent Move

September 9, 2021

There has been no news about Jaguar Health Inc (NASDAQ:JAGX) in recent days but the company is in considerable focus among investors and that might be related to a development from back in August. Back on August 23, the company’s fully owned subsidiary company Napo Pharmaceuticals made a key announcement with regards to a clinical study. At the time, Napo announced that an abstract which is related to an exploratory…


Jaguar Health Inc (NASDAQ:JAGX) Stock In Focus After The Latest Development

September 7, 2021

The news of a reverse stock split is almost always welcomed with a degree of trepidation by investors and hence, it was no surprise when the Jaguar Health Inc (NASDAQ:JAGX) declined last Friday. The company announced that it was going to have a reverse stock split of its outstanding and issued common shares and the stock promptly fell by as much as 3.50%. This morning, the stock is expected to…


Jaguar Health Inc (NASDAQ:JAGX) Stock Attempts To Recover After The Recent Fall

August 24, 2021

A wholly-owned subsidiary of Jaguar Health Inc (NASDAQ:JAGX), Napo Pharmaceuticals, on August 23, 2021, announced an abstract related to an exploratory clinical study. It delves into the impact of crofelemer on the gastrointestinal microbiome in people suffering from AIDS and has been given for presentation consideration at IDWeek 2021, taking place virtually from September 29 to October 3. Mytesi (crofelemer), an antidiarrheal drug for the relief of noninfectiousdiarrhea in adults…


Jaguar Health Inc (NASDAQ:JAGX) Stock Reports Quarterly Earnings: Stock Falls

August 16, 2021

Jaguar Health Inc (NASDAQ:JAGX) fell 6.75% after announcing its consolidated Q2 2021 financial results. During the quarter Mytesi, prescription volume was up 4.3% from Q1 2021, with net prescriptions increasing 2.8% over the same period. However, YoY prescription volume was down 9%, which the company attributes to the role of the pandemic leading to fewer patient visits, few refills, and fewer opportunities for Mytesi patients’ diagnosis. Mytesus net revenue was…